Literature DB >> 29329918

Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Alice Y Guh1, Yi Mu2, James Baggs2, Lisa G Winston3, Wendy Bamberg4, Carol Lyons5, Monica M Farley6, Lucy E Wilson7, Stacy M Holzbauer8, Erin C Phipps9, Zintars G Beldavs10, Marion A Kainer11, Maria Karlsson2, Dale N Gerding12, Ghinwa Dumyati13.   

Abstract

During 2011-2015, the adjusted long-term-care facility onset Clostridium difficile infection incidence rate in persons aged ≥65 years decreased annually by 17.45% (95% confidence interval, 14.53%-20.43%) across 10 US sites. A concomitant decline in inpatient fluoroquinolone use and the C difficile epidemic strain NAP1/027 among persons aged ≥65 years may have contributed to the decrease in long-term-care facility-onset C difficile infection incidence rate. Published by Elsevier Inc.

Entities:  

Keywords:  Fluoroquinolone; NAP1/027

Mesh：

Year:  2018        PMID： 29329918      PMCID： PMC6489441          DOI： 10.1016/j.ajic.2017.11.026

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  7 in total

1.  Acquisition of Clostridium difficile Colonization and Infection After Transfer From a Veterans Affairs Hospital to an Affiliated Long-Term Care Facility.

Authors:  Suresh Ponnada; Dubert M Guerrero; Lucy A Jury; Michelle M Nerandzic; Jennifer L Cadnum; M Jahangir Alam; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2017-07-11       Impact factor: 3.254

2.  Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.

Authors:  M H Wilcox; N Shetty; W N Fawley; M Shemko; P Coen; A Birtles; M Cairns; M D Curran; K J Dodgson; S M Green; K J Hardy; P M Hawkey; J G Magee; A D Sails; M W D Wren
Journal:  Clin Infect Dis       Date:  2012-07-11       Impact factor: 9.079

3.  Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands.

Authors:  M P Hensgens; A Goorhuis; D W Notermans; B H van Benthem; E J Kuijper
Journal:  Euro Surveill       Date:  2009-11-12

4.  Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.

Authors:  Timothy Lawes; José-María Lopez-Lozano; Cesar A Nebot; Gillian Macartney; Rashmi Subbarao-Sharma; Karen D Wares; Carolyn Sinclair; Ian M Gould
Journal:  Lancet Infect Dis       Date:  2016-11-04       Impact factor: 25.071

5.  Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.

Authors:  James Baggs; Scott K Fridkin; Lori A Pollack; Arjun Srinivasan; John A Jernigan
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

6.  Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.

Authors:  George Killgore; Angela Thompson; Stuart Johnson; Jon Brazier; Ed Kuijper; Jacques Pepin; Eric H Frost; Paul Savelkoul; Brad Nicholson; Renate J van den Berg; Haru Kato; Susan P Sambol; Walter Zukowski; Christopher Woods; Brandi Limbago; Dale N Gerding; L Clifford McDonald
Journal:  J Clin Microbiol       Date:  2007-11-26       Impact factor: 5.948

7.  Effects of control interventions on Clostridium difficile infection in England: an observational study.

Authors:  Kate E Dingle; Xavier Didelot; T Phuong Quan; David W Eyre; Nicole Stoesser; Tanya Golubchik; Rosalind M Harding; Daniel J Wilson; David Griffiths; Alison Vaughan; John M Finney; David H Wyllie; Sarah J Oakley; Warren N Fawley; Jane Freeman; Kirsti Morris; Jessica Martin; Philip Howard; Sherwood Gorbach; Ellie J C Goldstein; Diane M Citron; Susan Hopkins; Russell Hope; Alan P Johnson; Mark H Wilcox; Timothy E A Peto; A Sarah Walker; Derrick W Crook
Journal:  Lancet Infect Dis       Date:  2017-01-25       Impact factor: 71.421
  7 in total
  6 in total

1.  Incidence and economic burden of Clostridioides difficile infection in Ontario: a retrospective population-based study.

Authors:  Jennifer A Pereira; Allison McGeer; Antigona Tomovici; Alex Selmani; Ayman Chit
Journal:  CMAJ Open       Date:  2020-01-30

2.  Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.

Authors:  Edward Goldstein; Derek R MacFadden; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  Int J Antimicrob Agents       Date:  2019-03-06       Impact factor: 5.283

3.  Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

Authors:  Alice Y Guh; Yi Mu; Lisa G Winston; Helen Johnston; Danyel Olson; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Ghinwa K Dumyati; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 91.245

4.  Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System.

Authors:  Chengwen Teng; Kelly R Reveles; Obiageri O Obodozie-Ofoegbu; Christopher R Frei
Journal:  Int J Med Sci       Date:  2019-05-07       Impact factor: 3.738

5.  Epidemiology and outcomes of Clostridium difficile infection among hospitalised patients: results of a multicentre retrospective study in South Africa.

Authors:  Laurel Legenza; Susanne Barnett; Warren Rose; Monica Bianchini; Nasia Safdar; Renier Coetzee
Journal:  BMJ Glob Health       Date:  2018-07-15

6.  Phylogenomic analysis of Clostridioides difficile ribotype 106 strains reveals novel genetic islands and emergent phenotypes.

Authors:  Bryan Angelo P Roxas; Jennifer Lising Roxas; Rachel Claus-Walker; Anusha Harishankar; Asad Mansoor; Farhan Anwar; Shobitha Jillella; Alison Williams; Jason Lindsey; Sean P Elliott; Kareem W Shehab; V K Viswanathan; Gayatri Vedantam
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.